Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.269 USD | -1.62% | -0.85% | -15.39% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Immunic, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Immunic, Inc.
Wedbush | |
SVB Securities LLC | |
HC Wainwright | |
Piper Sandler | |
Aegis Capital | |
JMP Securities |
EPS Revisions
- Stock Market
- Equities
- IMUX Stock
- Consensus Immunic, Inc.